Skip to main content
. Author manuscript; available in PMC: 2021 Jan 1.
Published in final edited form as: Clin Lung Cancer. 2019 Nov 25;21(1):21–27.e5. doi: 10.1016/j.cllc.2019.07.008

Table 4.

Number of QTc-prolonging medications taken by patients according to time interval

Total number of QTc- prolonging medications (known or possible risk of TdP) Proportion of patients (%) by time-frame prior to or at diagnosis
3 months 6 months 12 months
1 21.2 22.8 23.9
2 5.7 7.3 9.2
3 1.3 1.9 3.0
≥4 0.3 0.6 1.3

TdP, torsades de pointes